日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

将多替拉韦转化为超长效注射用前药制剂

Deodhar, Suyash; Sillman, Brady; Bade, Aditya N; Avedissian, Sean N; Podany, Anthony T; McMillan, JoEllyn M; Gautam, Nagsen; Hanson, Brandon; Dyavar Shetty, Bhagya L; Szlachetka, Adam; Johnston, Morgan; Thurman, Michellie; Munt, Daniel J; Dash, Alekha K; Markovic, Milica; Dahan, Arik; Alnouti, Yazen; Yazdi, Alborz; Kevadiya, Bhavesh D; Byrareddy, Siddappa N; Cohen, Samuel M; Edagwa, Benson; Gendelman, Howard E

Analyte recovery in LC-MS/MS bioanalysis: An old issue revisited

液相色谱-串联质谱生物分析中分析物回收率:一个老问题的再探讨

Kumar, Devendra; Gautam, Nagsen; Alnouti, Yazen

Comparison of side-chain dispersion in protein structures determined by cryo-EM and X-ray crystallography

利用冷冻电镜和X射线晶体衍射法测定的蛋白质结构中侧链分散性的比较

Ravikumar, Ashraya; Gopnarayan, Mrugsen Nagsen; Subramaniam, Sriram; Srinivasan, Narayanaswamy

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles

将替诺福韦转化为具有长效药代动力学特征的稳定ProTide纳米晶体

Cobb, Denise A; Smith, Nathan; Deodhar, Suyash; Bade, Aditya N; Gautam, Nagsen; Shetty, Bhagya Laxmi Dyavar; McMillan, JoEllyn; Alnouti, Yazen; Cohen, Samuel M; Gendelman, Howard E; Edagwa, Benson

The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice

选择性 PPAR-delta 激动剂 seladelpar 通过恢复小鼠肠道屏障功能和胆汁酸稳态来减少乙醇诱发的肝病

Huikuan Chu, Lu Jiang, Bei Gao, Nagsen Gautam, Jawaher A Alamoudi, Sonja Lang, Yanhan Wang, Yi Duan, Yazen Alnouti, Edward E Cable, Bernd Schnabl

Intramuscular and subcutaneous administration of antiretroviral drugs, compared with oral, enhances delivery to lymphoid tissues in BALB/c mice.

与口服相比,肌肉注射和皮下注射抗逆转录病毒药物可增强 BALB/c 小鼠淋巴组织的药物递送

Dyavar Shetty Ravi, Kumar Sushil, Gautam Nagsen, Podany Anthony T, Winchester Lee C, Weinhold Jonathan A, Mykris Timothy M, Nallasamy Palanisamy, Alnouti Yazen, Fletcher Courtney V

Bile acid indices as biomarkers for liver diseases II: The bile acid score survival prognostic model

胆汁酸指标作为肝脏疾病生物标志物 II:胆汁酸评分生存预后模型

Alamoudi, Jawaher Abdullah; Li, Wenkuan; Gautam, Nagsen; Olivera, Marco; Meza, Jane; Mukherjee, Sandeep; Alnouti, Yazen

Bile acid indices as biomarkers for liver diseases I: Diagnostic markers

胆汁酸指标作为肝脏疾病的生物标志物 I:诊断标志物

Alamoudi, Jawaher Abdullah; Li, Wenkuan; Gautam, Nagsen; Olivera, Marco; Meza, Jane; Mukherjee, Sandeep; Alnouti, Yazen

A year-long extended release nanoformulated cabotegravir prodrug

一种缓释纳米制剂的卡博特韦前药,有效期长达一年。

Kulkarni, Tanmay A; Bade, Aditya N; Sillman, Brady; Shetty, Bhagya Laxmi Dyavar; Wojtkiewicz, Melinda S; Gautam, Nagsen; Hilaire, James R; Sravanam, Sruthi; Szlachetka, Adam; Lamberty, Benjamin G; Morsey, Brenda M; Fox, Howard S; Alnouti, Yazen; McMillan, JoEllyn M; Mosley, R Lee; Meza, Jane; Domanico, Paul L; Yue, Tai-Yuen; Moore, Gary; Edagwa, Benson J; Gendelman, Howard E

Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice

在易患狼疮的NZB/WF1小鼠中,对两种地塞米松前药纳米制剂进行了头对头比较药代动力学和生物分布(PK/BD)研究。

Wei, Xin; Zhao, Gang; Wang, Xiaobei; Gautam, Nagsen; Jia, Zhenshan; Zhao, Zhifeng; Kong, Dexuan; Zhang, Fan; Kumar, Sushil; Sun, Yuanyuan; Chen, Ningrong; Wang, Xiaoyan; Yang, Libin; Ren, Rongguo; Thiele, Geoffrey M; Bronich, Tatiana K; O'Dell, James R; Alnouti, Yazen; Wang, Dong